Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-10T05:11:49.728Z Has data issue: false hasContentIssue false
  • English
  • Français

Outcomes of an Enhanced Surveillance Program for Carbapenem-Resistant Enterobacteriaceae

Published online by Cambridge University Press:  10 May 2016

Margaret Fitzpatrick ,
Teresa Zembower ,
Michael Malczynski ,
Chao Qi  and
Maureen K. Bolon
Margaret Fitzpatrick*
Affiliation:
Department of Medicine, Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois
Teresa Zembower
Affiliation:
Department of Medicine, Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois
Michael Malczynski
Affiliation:
Clinical Microbiology Laboratory, Northwestern Memorial Hospital, Chicago, Illinois
Chao Qi
Affiliation:
Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
Maureen K. Bolon
Affiliation:
Department of Medicine, Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois
*
645 North Michigan Avenue, Suite 900, Chicago, IL 60611 (margaret-fitzpatrick-0@northwestern.edu).
Get access Rights & Permissions [Opens in a new window]

Abstract

Optimal surveillance strategies for identifying patients colonized with and at risk for transmitting carbapenem-resistant Enterobacteriaceae (CRE) are urgently needed. We instituted an enhanced surveillance program for CRE that identified unrecognized CRE-colonized patients but failed to identify possible CRE transmissions. We also identified risk factors associated with transmitting CRE.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 35 , Issue 4: Special Topic Issue: Carbapenem-Resistant Enterobacteriaceae and Multidrug-Resistant Organisms , April 2014 , pp. 419 - 422
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2014

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Centers for Disease Control and Prevention. Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep 2013;62:165–170.Google Scholar
2. Correa, L, Martino, MD, Siqueira, I, et al. A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection. BMC Infect Dis 2013;13:80.CrossRefGoogle ScholarPubMed
3. Gupta, N, Limbago, BM, Patel, JB, Kallen, AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011;53:60–67.CrossRefGoogle ScholarPubMed
4. Patel, G, Huprikar, S, Factor, SH, Jenkins, SG, Calfee, DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29:1099–1106.CrossRefGoogle ScholarPubMed
5. Centers for Disease Control and Prevention. 2012 CRE tool-kit: guidance for control of carbapenem-resistant Enterobacteriaceae (CRE). http://www.cdc.gov/hai/organisms/cre/cre-toolkit/index.html. Published June 21, 2010. Accessed December 10, 2012.Google Scholar
6. Chitnis, AS, Caruthers, PS, Rao, AK, et al. Outbreak of carbapenem-resistant Enterobacteriaceae at a long-term acute care hospital: sustained reductions in transmission through active surveillance and targeted interventions. Infect Control Hosp Epidemiol 2012;33:984–992.CrossRefGoogle Scholar
7. Munoz-Price, LS, Hayden, MK, Lolans, K, et al. Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a long-term acute care hospital. Infect Control Hosp Epidemiol 2010;31:341–347.CrossRefGoogle Scholar
8. Schwaber, MJ, Lev, B, Israeli, A, et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011;52:848–855.CrossRefGoogle Scholar
9. Calfee, D, Jenkins, SG. Use of active surveillance cultures to detect asymptomatic colonization with carbapenem-resistant Klebsiella pneumoniae in intensive care unit patients. Infect Control Hosp Epidemiol 2008;29:966–968.CrossRefGoogle ScholarPubMed
10. Snitkin, ES, Zelazny, AM, Thomas, PJ, et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 2012;4:148ra116.CrossRefGoogle ScholarPubMed